在BioDeep NovoCell知识数据库中,参考离子总共被划分为4个级别。
  • Confirmed: 这个参考离子已经通过手动审计得到确认和验证。
  • Reliable: 这个参考离子可能在特定的解剖组织环境中高度保守。
  • Unreliable: 这个参考离子具有较高的排名价值,但缺乏可重复性。
  • Unavailable: 由于排名价值低且缺乏可重复性,这个参考离子不应用于注释。

Found 30 Reference Ions Near m/z 534.2977
NovoCell ID m/z Mass Window Metabolite Ranking Anatomy Context
MSI_000006572 Reliable 534.2904 534.2903 ~ 534.2906
MzDiff: 1.5 ppm
Udenafil (BioDeep_00000018054)
Formula: C25H36N6O4S (516.2519)
5.36 (47%) Rattus norvegicus
[UBERON:0004358] caput epididymis
MSI_000020284 Reliable 534.3013 534.3011 ~ 534.3014
MzDiff: 1.3 ppm
Corchoroside A (BioDeep_00000007024)
Formula: C29H42O9 (534.2829)
5.13 (31%) Rattus norvegicus
[UBERON:0004358] caput epididymis
MSI_000063311 Reliable 534.2951 534.2951 ~ 534.2951
MzDiff: 0.2 ppm
Eriojaposide B (BioDeep_00000011945)
Formula: C25H40O11 (516.257)
0.67 (100%) Mus musculus
[UBERON:0000956] cerebral cortex
MSI_000006732 Reliable 534.2966 534.2965 ~ 534.2966
MzDiff: 0.7 ppm
Eriojaposide B (BioDeep_00000011945)
Formula: C25H40O11 (516.257)
5.09 (100%) Rattus norvegicus
[UBERON:0004358] caput epididymis
MSI_000011674 Unavailable 534.3076 534.3076 ~ 534.3076
MzDiff: none
(3s,6r)-6-{[(2s,10r,10ar)-10-methyl-4-oxo-2-phenyl-1h,2h,3h,10ah-pyrimido[1,2-a]indol-10-yl]methyl}-3-(cyclohexylmethyl)-1,5-dihydroxy-3,6-dihydropyrazin-2-one (BioDeep_00002224743)
Formula: C30H36N4O4 (516.2736)
-1.98 (100%) Mus musculus
[UBERON:0012378] muscle layer of urinary bladder
MSI_000010447 Unavailable 534.2958 534.2958 ~ 534.2958
MzDiff: 0.0 ppm
Eriojaposide B (BioDeep_00000011945)
Formula: C25H40O11 (516.257)
-1.45 (100%) Bathymodiolus
[UBERON:0009120] gill filament
MSI_000061258 Unreliable 534.2963 534.2963 ~ 534.2964
MzDiff: 0.2 ppm
8-{2-Methyl-5-[2-oxo-2-(4-phenyl-piperazin-1-yl)-ethoxy]-2H-pyrazol-3-yl}-1,3-dipropyl-3,7-dihydro-purine-2,6-dione (BioDeep_00000176241)
Formula: C27H34N8O4 (534.2703)
1.51 (67%) Mus musculus
[UBERON:0000956] cerebral cortex
MSI_000021513 Unreliable 534.2969 534.2969 ~ 534.2969
MzDiff: none
Eriojaposide B (BioDeep_00000011945)
Formula: C25H40O11 (516.257)
0.86 (100%) Mus musculus
[UBERON:0001499] muscle of arm
MSI_000008985 Unreliable 534.293 534.293 ~ 534.293
MzDiff: none
Eriojaposide B (BioDeep_00000011945)
Formula: C25H40O11 (516.257)
3.17 (100%) Mus musculus
[UBERON:0004645] urinary bladder urothelium
MSI_000007822 534.2947 534.2947 ~ 534.2948
MzDiff: 0.2 ppm
Eriojaposide B (BioDeep_00000011945)
Formula: C25H40O11 (516.257)
1.48 (100%) Rattus norvegicus
[UBERON:0004359] corpus epididymis
MSI_000009232 Unreliable 534.2999 534.2999 ~ 534.2999
MzDiff: none
Corchoroside A (BioDeep_00000007024)
Formula: C29H42O9 (534.2829)
2.71 (100%) Mus musculus
[UBERON:0004645] urinary bladder urothelium
MSI_000011970 Unavailable 534.2958 534.2958 ~ 534.2958
MzDiff: none
Eriojaposide B (BioDeep_00000011945)
Formula: C25H40O11 (516.257)
-0.68 (100%) Bathymodiolus
[UBERON:2000211] gill lamella
MSI_000009271 Unreliable 534.3076 534.3076 ~ 534.3076
MzDiff: none
(3s,6r)-6-{[(2s,10r,10ar)-10-methyl-4-oxo-2-phenyl-1h,2h,3h,10ah-pyrimido[1,2-a]indol-10-yl]methyl}-3-(cyclohexylmethyl)-1,5-dihydroxy-3,6-dihydropyrazin-2-one (BioDeep_00002224743)
Formula: C30H36N4O4 (516.2736)
1.77 (100%) Mus musculus
[UBERON:0004645] urinary bladder urothelium
MSI_000001486 Unavailable 534.2933 534.2933 ~ 534.2933
MzDiff: none
Eriojaposide B (BioDeep_00000011945)
Formula: C25H40O11 (516.257)
-0.01 (100%) Mus musculus
[UBERON:0001225] cortex of kidney
MSI_000002377 Unavailable 534.2933 534.2933 ~ 534.2933
MzDiff: none
Eriojaposide B (BioDeep_00000011945)
Formula: C25H40O11 (516.257)
-0.96 (100%) Mus musculus
[UBERON:0001293] outer medulla of kidney
MSI_000032107 Unreliable 534.2953 534.2953 ~ 534.2953
MzDiff: none
7,8-Dihydrovomifoliol 9-[rhamnosyl-(1->6)-glucoside] (BioDeep_00000026029)
Formula: C25H42O12 (534.2676)
2.42 (100%) Posidonia oceanica
[PO:0005020] vascular bundle
MSI_000033976 Unreliable 534.2953 534.2953 ~ 534.2953
MzDiff: none
7,8-Dihydrovomifoliol 9-[rhamnosyl-(1->6)-glucoside] (BioDeep_00000026029)
Formula: C25H42O12 (534.2676)
0.14 (100%) Posidonia oceanica
[PO:0005352] xylem
MSI_000044188 Unreliable 534.2956 534.2956 ~ 534.2956
MzDiff: none
Eriojaposide B (BioDeep_00000011945)
Formula: C25H40O11 (516.257)
0.75 (100%) Rattus norvegicus
[UBERON:0002264] olfactory bulb
MSI_000049642 Unreliable 534.2956 534.2956 ~ 534.2956
MzDiff: none
Eriojaposide B (BioDeep_00000011945)
Formula: C25H40O11 (516.257)
1.73 (100%) Mytilus edulis
[UBERON:0009120] gill filament
MSI_000050945 Unreliable 534.2956 534.2956 ~ 534.2956
MzDiff: none
Eriojaposide B (BioDeep_00000011945)
Formula: C25H40O11 (516.257)
0.53 (100%) Mytilus edulis
[UBERON:2001856] gill ray
MSI_000059781 Unavailable 534.2957 534.2957 ~ 534.2957
MzDiff: none
Eriojaposide B (BioDeep_00000011945)
Formula: C25H40O11 (516.257)
-0.54 (100%) Mus musculus
[UBERON:0002298] brainstem
MSI_000060996 Unavailable 534.2964 534.2964 ~ 534.2964
MzDiff: none
Eriojaposide B (BioDeep_00000011945)
Formula: C25H40O11 (516.257)
-0.06 (100%) Mus musculus
[UBERON:0002421] hippocampal formation
MSI_000028243 Unreliable 534.2907 534.2907 ~ 534.2907
MzDiff: none
Eriojaposide B (BioDeep_00000011945)
Formula: C25H40O11 (516.257)
1.62 (100%) Macropus giganteus
[UBERON:0001891] midbrain
MSI_000023198 Unreliable 534.2969 534.2969 ~ 534.2969
MzDiff: none
Eriojaposide B (BioDeep_00000011945)
Formula: C25H40O11 (516.257)
0.47 (100%) Mus musculus
[UBERON:0004250] upper arm bone
MSI_000013476 Unreliable 534.2973 534.2973 ~ 534.2973
MzDiff: none
8-{2-Methyl-5-[2-oxo-2-(4-phenyl-piperazin-1-yl)-ethoxy]-2H-pyrazol-3-yl}-1,3-dipropyl-3,7-dihydro-purine-2,6-dione (BioDeep_00000176241)
Formula: C27H34N8O4 (534.2703)
1.05 (100%) Plant
[PO:0005417] phloem
MSI_000014634 Unreliable 534.2973 534.2973 ~ 534.2973
MzDiff: none
8-{2-Methyl-5-[2-oxo-2-(4-phenyl-piperazin-1-yl)-ethoxy]-2H-pyrazol-3-yl}-1,3-dipropyl-3,7-dihydro-purine-2,6-dione (BioDeep_00000176241)
Formula: C27H34N8O4 (534.2703)
0.17 (100%) Plant
[PO:0006036] root epidermis
MSI_000019145 Unavailable 534.2973 534.2973 ~ 534.2973
MzDiff: none
8-{2-Methyl-5-[2-oxo-2-(4-phenyl-piperazin-1-yl)-ethoxy]-2H-pyrazol-3-yl}-1,3-dipropyl-3,7-dihydro-purine-2,6-dione (BioDeep_00000176241)
Formula: C27H34N8O4 (534.2703)
-0.98 (100%) Plant
[PO:0020124] root stele
MSI_000019361 Unreliable 534.2973 534.2973 ~ 534.2973
MzDiff: none
8-{2-Methyl-5-[2-oxo-2-(4-phenyl-piperazin-1-yl)-ethoxy]-2H-pyrazol-3-yl}-1,3-dipropyl-3,7-dihydro-purine-2,6-dione (BioDeep_00000176241)
Formula: C27H34N8O4 (534.2703)
0.85 (100%) Plant
[PO:0025197] stele
MSI_000003010 Unavailable 534.2976 534.2976 ~ 534.2976
MzDiff: none
(1s,2's,4'r)-2',6,7,10''-tetramethoxy-5''-methyl-2,3,4,9-tetrahydrodispiro[pyrido[3,4-b]indole-1,1'-cyclohexane-4',2''-[5]azatricyclo[6.3.1.0⁴,¹²]dodecane]-1''(11''),8''(12''),9''-trien-11''-ol (BioDeep_00002085375)
Formula: C31H39N3O5 (533.289)
-0.88 (100%) Rattus norvegicus
[UBERON:0001950] neocortex
MSI_000003314 Unavailable 534.2976 534.2976 ~ 534.2976
MzDiff: none
(1s,2's,4'r)-2',6,7,10''-tetramethoxy-5''-methyl-2,3,4,9-tetrahydrodispiro[pyrido[3,4-b]indole-1,1'-cyclohexane-4',2''-[5]azatricyclo[6.3.1.0⁴,¹²]dodecane]-1''(11''),8''(12''),9''-trien-11''-ol (BioDeep_00002085375)
Formula: C31H39N3O5 (533.289)
-0.19 (100%) Rattus norvegicus
[UBERON:0002037] cerebellum

Found 31 Sample Hits
Metabolite Species Sample
Eriojaposide B

Formula: C25H40O11 (516.257)
Adducts: [M+NH4]+ (Ppm: 4)
Mus musculus (Urinary bladder)
HR2MSI_mouse_urinary_bladder - S096
Resolution: 10μm, 260x134

Description

Mass spectrometry imaging of phospholipids in mouse urinary bladder (imzML dataset)
The spatial distribution of phospholipids in a tissue section of mouse urinary bladder was analyzed by MALDI MS imaging at 10 micrometer pixel size with high mass resolution (using an LTQ Orbitrap mass spectrometer).

R, ö, mpp A, Guenther S, Schober Y, Schulz O, Takats Z, Kummer W, Spengler B, Histology by mass spectrometry: label-free tissue characterization obtained from high-accuracy bioanalytical imaging. Angew Chem Int Ed Engl, 49(22):3834-8(2010)

Fig. S2: Single ion images of compounds shown in Fig. 1A-B : (upper left to lower right) m/z = 743.5482 (unknown), m/z = 741.5307 (SM (16:0), [M+K]+), m/z = 798.5410 (PC (34:1), [M+K]+), m/z = 616.1767 (heme b, M+), m/z = 772.5253 (PC (32:0), [M+K]+).

Stability of determined mass values was in the range of +/- 1 ppm over 22 hours of measurement (Fig. S4), with a standard deviation of 0.56 ppm. Accuracy data were obtained during tissue scanning experiments by monitoring the mass signal at nominal mass 798. The internal lock mass function of the Orbitrap instrument was used for automatic calibration during imaging measurements, using the known matrix-related ion signals at m/z = 137.0233, m/z = 444.0925 and m/z = 716.1246.

Eriojaposide B

Formula: C25H40O11 (516.257)
Adducts: [M+NH4]+ (Ppm: 4.5)
Mus musculus (Kidney)
FULL_MS_centriod_CHCA_20210819
Resolution: 17μm, 638x437

Description

AP-MALDI instrument demo test, mass spectrum scan in centroid mode.

8-{2-Methyl-5-[2-oxo-2-(4-phenyl-piperazin-1-yl)-ethoxy]-2H-pyrazol-3-yl}-1,3-dipropyl-3,7-dihydro-purine-2,6-dione

Formula: C27H34N8O4 (534.2703)
Adducts: [M-H2O+NH4]+ (Ppm: 7)
Plant (Root)
MPIMM_035_QE_P_PO_6pm
Resolution: 30μm, 165x170

Description

(1s,2's,4'r)-2',6,7,10''-tetramethoxy-5''-methyl-2,3,4,9-tetrahydrodispiro[pyrido[3,4-b]indole-1,1'-cyclohexane-4',2''-[5]azatricyclo[6.3.1.0⁴,¹²]dodecane]-1''(11''),8''(12''),9''-trien-11''-ol

Formula: C31H39N3O5 (533.289)
Adducts: [M+H]+ (Ppm: 2)
Rattus norvegicus (Brain)
Spectroswiss - sol_2x_br_2
Resolution: 17μm, 488x193

Description

Eriojaposide B

Formula: C25H40O11 (516.257)
Adducts: [M+NH4]+ (Ppm: 9.6)
Rattus norvegicus (Epididymis)
epik_dhb_head_ito08_43
Resolution: 17μm, 298x106

Description

Eriojaposide B

Formula: C25H40O11 (516.257)
Adducts: [M+NH4]+ (Ppm: 10.7)
Rattus norvegicus (Epididymis)
epik_dhb_head_ito08_44
Resolution: 17μm, 299x111

Description

Eriojaposide B

Formula: C25H40O11 (516.257)
Adducts: [M+NH4]+ (Ppm: 9.6)
Rattus norvegicus (Epididymis)
epik_dhb_head_ito08_47
Resolution: 17μm, 301x111

Description

Eriojaposide B

Formula: C25H40O11 (516.257)
Adducts: [M+NH4]+ (Ppm: 10.5)
Rattus norvegicus (Epididymis)
epik_dhb_head_ito08_48
Resolution: 17μm, 294x107

Description

Eriojaposide B

Formula: C25H40O11 (516.257)
Adducts: [M+NH4]+ (Ppm: 8.7)
Rattus norvegicus (Epididymis)
epik_dhb_head_ito01_04
Resolution: 17μm, 178x91

Description

Udenafil

Formula: C25H36N6O4S (516.2519)
Adducts: [M+NH4]+ (Ppm: 9.2)
Rattus norvegicus (Epididymis)
epik_dhb_head_ito01_03
Resolution: 17μm, 159x110

Description

Eriojaposide B

Formula: C25H40O11 (516.257)
Adducts: [M+NH4]+ (Ppm: 11.1)
Rattus norvegicus (Epididymis)
epik_dhb_head_ito01_03
Resolution: 17μm, 159x110

Description

Corchoroside A

Formula: C29H42O9 (534.2829)
Adducts: [M]+ (Ppm: 15.3)
Rattus norvegicus (normal)
epik_dhb_head_ito01_05
Resolution: 17μm, 183x105

Description

Eriojaposide B

Formula: C25H40O11 (516.257)
Adducts: [M+NH4]+ (Ppm: 8.8)
Rattus norvegicus (normal)
epik_dhb_head_ito01_05
Resolution: 17μm, 183x105

Description

Eriojaposide B

Formula: C25H40O11 (516.257)
Adducts: [M+NH4]+ (Ppm: 9.6)
Rattus norvegicus (Epididymis)
epik_dhb_head_ito01_06
Resolution: 17μm, 183x103

Description

PA(2:0/20:3(5Z,8Z,11Z)-O(14R,15S))

Formula: C25H41O9P (516.2488)
Adducts: [M+NH4]+ (Ppm: 16.4)
Mus musculus (Lung)
image1
Resolution: 40μm, 187x165

Description

Fig. 2 MALDI-MSI data from the same mouse lung tissue analyzed in Fig. 1. A: Optical image of the post-MSI, H&E-stained tissue section. B–D, F–G: Ion images of (B) m/z 796.6855 ([U13C-DPPC+Na]+), (C) m/z 756.5514 ([PC32:0+Na]+), (D) m/z 765.6079 ([D9-PC32:0+Na]+), (F) m/z 754.5359 ([PC32:1+Na]+), and (G) m/z 763.5923 ([D9-PC32:1+Na]+). E, H: Ratio images of (E) [D9-PC32:0+Na]+:[PC32:0+Na]+ and (H) [D9-PC32:1+Na]+:[PC32:1+Na]+. Part-per-million (ppm) mass errors are indicated in parentheses. All images were visualized using total-ion-current normalization and using hotspot removal (high quantile = 99%). DPPC = PC16:0/16:0. U13C-DPPC, universally 13C-labeled dipalmitoyl PC; PC, phosphatidylcholine; MSI, mass spectrometry imaging; H&E, hematoxylin and eosin. Fig 1-3, Fig S1-S3, S5

Eriojaposide B

Formula: C25H40O11 (516.257)
Adducts: [M+NH4]+ (Ppm: 12.8)
Mus musculus (Lung)
image1
Resolution: 40μm, 187x165

Description

Fig. 2 MALDI-MSI data from the same mouse lung tissue analyzed in Fig. 1. A: Optical image of the post-MSI, H&E-stained tissue section. B–D, F–G: Ion images of (B) m/z 796.6855 ([U13C-DPPC+Na]+), (C) m/z 756.5514 ([PC32:0+Na]+), (D) m/z 765.6079 ([D9-PC32:0+Na]+), (F) m/z 754.5359 ([PC32:1+Na]+), and (G) m/z 763.5923 ([D9-PC32:1+Na]+). E, H: Ratio images of (E) [D9-PC32:0+Na]+:[PC32:0+Na]+ and (H) [D9-PC32:1+Na]+:[PC32:1+Na]+. Part-per-million (ppm) mass errors are indicated in parentheses. All images were visualized using total-ion-current normalization and using hotspot removal (high quantile = 99%). DPPC = PC16:0/16:0. U13C-DPPC, universally 13C-labeled dipalmitoyl PC; PC, phosphatidylcholine; MSI, mass spectrometry imaging; H&E, hematoxylin and eosin. Fig 1-3, Fig S1-S3, S5

Eriojaposide B

Formula: C25H40O11 (516.257)
Adducts: [M+NH4]+ (Ppm: 11.3)
Mus musculus (Left upper arm)
357_l_total ion count
Resolution: 50μm, 97x131

Description

Diseased

Eriojaposide B

Formula: C25H40O11 (516.257)
Adducts: [M+NH4]+ (Ppm: 7.2)
Mus musculus (Lung)
image3
Resolution: 40μm, 146x190

Description

Fig. 4 MALDI-MSI data of mouse lung tissue after administration with D9-choline and U13C-DPPC–containing Poractant alfa surfactant (labels administered 12 h prior to tissue collection). Ion images of (A) m/z 796.6856 ([U13C-DPPC+Na]+), (B) m/z 756.5154 [PC32:0+Na]+), and (C) m/z 765.6079 ([D9-PC32:0+Na]+). D: Overlay image of [U13C-PC32:0+Na]+ (red) and [D9-PC32:0+Na]+ (green). Part-per-million (ppm) mass errors are indicated in parentheses. All images were visualized using total-ion-current normalization and using hotspot removal (high quantile = 99%). DPPC = PC16:0/16:0. MSI, mass spectrometry imaging; PC, phosphatidylcholine; U13C-DPPC, universally 13C-labeled dipalmitoyl PC.

PA(2:0/20:3(5Z,8Z,11Z)-O(14R,15S))

Formula: C25H41O9P (516.2488)
Adducts: [M+NH4]+ (Ppm: 16.4)
Mus musculus (Lung)
image4
Resolution: 40μm, 162x156

Description

Fig 6c Fig. 6 MALDI-MSI of U13C-PC16:0/16:0 acyl chain remodeling. A: Averaged MALDI mass spectrum from lung tissue collected from mice euthanized 12 h after administration of D9-choline and U13C-DPPC–containing Poractant alfa surfactant. The ion at m/z 828.6321 is assigned as the [M+Na]+ ion of 13C24-PC16:0_20:4 formed by acyl remodeling of U13C-PC16:0/16:0. The “NL” value refers to the intensity of the base peak in the full range MS1 spectrum. B: MS/MS spectrum of precursor ions at m/z 828.5 ± 0.5 with fragment ions originating from [13C24-PC16:0_20:4+Na]+ annotated. Part-per-million (ppm) mass errors are provided in parentheses. C, D: MALDI-MSI data of [U13C-DPPC+Na]+ (blue), [PC36:4+Na]+ (green) and [13C24-PC16:0_20:4+Na]+ (red) in lung tissue collected from mice (C) 12 h and (D) 18 h after label administration. All images were visualized using total-ion-current normalization and hotspot removal (high quantile = 99%). MS/MS, tandem mass spectrometry; MSI, mass spectrometry imaging; PC, phosphatidylcholine; U13C-DPPC, universally 13C-labeled dipalmitoyl PC.

Eriojaposide B

Formula: C25H40O11 (516.257)
Adducts: [M+NH4]+ (Ppm: 12.6)
Mus musculus (Lung)
image4
Resolution: 40μm, 162x156

Description

Fig 6c Fig. 6 MALDI-MSI of U13C-PC16:0/16:0 acyl chain remodeling. A: Averaged MALDI mass spectrum from lung tissue collected from mice euthanized 12 h after administration of D9-choline and U13C-DPPC–containing Poractant alfa surfactant. The ion at m/z 828.6321 is assigned as the [M+Na]+ ion of 13C24-PC16:0_20:4 formed by acyl remodeling of U13C-PC16:0/16:0. The “NL” value refers to the intensity of the base peak in the full range MS1 spectrum. B: MS/MS spectrum of precursor ions at m/z 828.5 ± 0.5 with fragment ions originating from [13C24-PC16:0_20:4+Na]+ annotated. Part-per-million (ppm) mass errors are provided in parentheses. C, D: MALDI-MSI data of [U13C-DPPC+Na]+ (blue), [PC36:4+Na]+ (green) and [13C24-PC16:0_20:4+Na]+ (red) in lung tissue collected from mice (C) 12 h and (D) 18 h after label administration. All images were visualized using total-ion-current normalization and hotspot removal (high quantile = 99%). MS/MS, tandem mass spectrometry; MSI, mass spectrometry imaging; PC, phosphatidylcholine; U13C-DPPC, universally 13C-labeled dipalmitoyl PC.

Eriojaposide B

Formula: C25H40O11 (516.257)
Adducts: [M+NH4]+ (Ppm: 7.2)
Mus musculus (Lung)
image5
Resolution: 40μm, 163x183

Description

Supplementary Figure S8. MALDI-MSI data of mouse lung tissue administered with D9-choline and U 13C-DPPC–containing Poractant alfa surfactant (labels administered 18 h prior to sacrifice). Ion images of (a) m/z 796.6856 ([U13C-DPPC+Na]+), (b) m/z 756.5154 [PC32:0+Na]+ and (c) m/z 765.6079 ([D9-PC32:0+Na]+). (d) Overlay image of [U13C-DPPC+Na]+ (red) and [D9-PC32:0+Na]+ (green). Parts per million (ppm) mass errors are indicated in parentheses. All images were visualised using totalion-current normalisation and using hotspot removal (high quantile = 99%). DPPC = PC16:0/16:0.

Eriojaposide B

Formula: C25H40O11 (516.257)
Adducts: [M+NH4]+ (Ppm: 8.5)
Mus musculus (Lung)
image2
Resolution: 40μm, 550x256

Description

Supplementary Figure S6. Ion distribution images for (a) [PC36:4+Na]+ (m/z 804.5514) and (b) [PC38:6+Na]+ (m/z 828.5515) obtained from mouse lung tissue collected 6 h after administration of D9- choline and U13C-DPPC–containing CHF5633. Parts-per-million (ppm) mass errors are indicated in parentheses. (c) Magnification of the boxed region in (a) with selected bronchiolar regions outlined in white boxes. (d) The corresponding H&E-stained tissue section with the same selected bronchiolar regions outlined in black boxes. These data demonstrate the co-localisation of the polyunsaturated lipids PC36:4 and PC38:6 with the bronchiolar regions of the lung. All MSI images were visualised using total ion current normalisation and hotspot removal (high quantile = 99%).

7,8-Dihydrovomifoliol 9-[rhamnosyl-(1->6)-glucoside]

Formula: C25H42O12 (534.2676)
Adducts: [M-H2O+NH4]+ (Ppm: 8.3)
Posidonia oceanica (root)
20190614_MS1_A19r-20
Resolution: 17μm, 262x276

Description

Seagrasses are one of the most efficient natural sinks of carbon dioxide (CO2) on Earth. Despite covering less than 0.1% of coastal regions, they have the capacity to bury up to 10% of marine organic matter and can bury the same amount of carbon 35 times faster than tropical rainforests. On land, the soil’s ability to sequestrate carbon is intimately linked to microbial metabolism. Despite the growing attention to the link between plant production, microbial communities, and the carbon cycle in terrestrial ecosystems, these processes remain enigmatic in the sea. Here, we show that seagrasses excrete organic sugars, namely in the form of sucrose, into their rhizospheres. Surprisingly, the microbial communities living underneath meadows do not fully use this sugar stock in their metabolism. Instead, sucrose piles up in the sediments to mM concentrations underneath multiple types of seagrass meadows. Sediment incubation experiments show that microbial communities living underneath a meadow use sucrose at low metabolic rates. Our metagenomic analyses revealed that the distinct community of microorganisms occurring underneath meadows is limited in their ability to degrade simple sugars, which allows these compounds to persist in the environment over relatively long periods of time. Our findings reveal how seagrasses form blue carbon stocks despite the relatively small area they occupy. Unfortunately, anthropogenic disturbances are threatening the long-term persistence of seagrass meadows. Given that these sediments contain a large stock of sugars that heterotopic bacteria can degrade, it is even more important to protect these ecosystems from degradation.

Eriojaposide B

Formula: C25H40O11 (516.257)
Adducts: [M+NH4]+ (Ppm: 8.3)
Mus musculus (Liver)
Salmonella_final_pos_recal
Resolution: 17μm, 691x430

Description

A more complete and holistic view on host–microbe interactions is needed to understand the physiological and cellular barriers that affect the efficacy of drug treatments and allow the discovery and development of new therapeutics. Here, we developed a multimodal imaging approach combining histopathology with mass spectrometry imaging (MSI) and same section imaging mass cytometry (IMC) to study the effects of Salmonella Typhimurium infection in the liver of a mouse model using the S. Typhimurium strains SL3261 and SL1344. This approach enables correlation of tissue morphology and specific cell phenotypes with molecular images of tissue metabolism. IMC revealed a marked increase in immune cell markers and localization in immune aggregates in infected tissues. A correlative computational method (network analysis) was deployed to find metabolic features associated with infection and revealed metabolic clusters of acetyl carnitines, as well as phosphatidylcholine and phosphatidylethanolamine plasmalogen species, which could be associated with pro-inflammatory immune cell types. By developing an IMC marker for the detection of Salmonella LPS, we were further able to identify and characterize those cell types which contained S. Typhimurium. [dataset] Nicole Strittmatter. Holistic Characterization of a Salmonella Typhimurium Infection Model Using Integrated Molecular Imaging, metabolights_dataset, V1; 2022. https://www.ebi.ac.uk/metabolights/MTBLS2671.

Eriojaposide B

Formula: C25H40O11 (516.257)
Adducts: [M+NH4]+ (Ppm: 10)
Mytilus edulis (mantle)
20190201_MS38_Crassostrea_Mantle_350-1500_DHB_pos_A28_10um_270x210
Resolution: 10μm, 270x210

Description

Eriojaposide B

Formula: C25H40O11 (516.257)
Adducts: [M+NH4]+ (Ppm: 8.8)
Mytilus edulis (gill)
20190202_MS38_Crassostrea_Gill_350-1500_DHB_pos_A25_11um_305x210
Resolution: 11μm, 305x210

Description

single cell layer class_4 is the gill structure cells, metabolite ion 534.2956 is the top representive ion of this type of cell

Eriojaposide B

Formula: C25H40O11 (516.257)
Adducts: [M+NH4]+ (Ppm: 9)
Mytilus edulis (mantle)
20190216_MS38_Mytilus_mantle_350-1500_DHB_pos_A26_10um_275x210
Resolution: 10μm, 275x210

Description

Eriojaposide B

Formula: C25H40O11 (516.257)
Adducts: [M+NH4]+ (Ppm: 9)
Mus musculus (brain)
Brain01_Bregma-3-88b_centroid
Resolution: 17μm, 265x320

Description

Eriojaposide B

Formula: C25H40O11 (516.257)
Adducts: [M+NH4]+ (Ppm: 10.3)
Mus musculus (brain)
Brain01_Bregma1-42_02_centroid
Resolution: 17μm, 434x258

Description

8-{2-Methyl-5-[2-oxo-2-(4-phenyl-piperazin-1-yl)-ethoxy]-2H-pyrazol-3-yl}-1,3-dipropyl-3,7-dihydro-purine-2,6-dione

Formula: C27H34N8O4 (534.2703)
Adducts: [M-H2O+NH4]+ (Ppm: 5.1)
Mus musculus (brain)
Brain01_Bregma1-42_01_centroid
Resolution: 17μm, 447x118

Description

Eriojaposide B

Formula: C25H40O11 (516.257)
Adducts: [M+NH4]+ (Ppm: 7.9)
Mus musculus (brain)
Brain02_Bregma-1-46
Resolution: 17μm, 294x399

Description